Pilar Archila

500 total citations
18 papers, 134 citations indexed

About

Pilar Archila is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Pilar Archila has authored 18 papers receiving a total of 134 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Pilar Archila's work include Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (5 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Pilar Archila is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (5 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Pilar Archila collaborates with scholars based in Colombia, Spain and Mexico. Pilar Archila's co-authors include Óscar Arrieta, Andrés F. Cardona, Arturo E. Hernández, Rafael Rosell, Kelly A. Vaughn, Carlos Vargas, Hernán Carranza, Claudio Martín, Jorge Otero and Leonardo Rojas and has published in prestigious journals such as Journal of Clinical Oncology, Annals of the New York Academy of Sciences and Human Brain Mapping.

In The Last Decade

Pilar Archila

15 papers receiving 133 citations

Peers

Countries citing papers authored by Pilar Archila

Since Specialization

Citations

This map shows the geographic impact of Pilar Archila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pilar Archila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pilar Archila more than expected).

Fields of papers citing papers by Pilar Archila

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pilar Archila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pilar Archila. The network helps show where Pilar Archila may publish in the future.

Co-authorship network of co-authors of Pilar Archila

This figure shows the co-authorship network connecting the top 25 collaborators of Pilar Archila. A scholar is included among the top collaborators of Pilar Archila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pilar Archila. Pilar Archila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Molecular Tumor Board Improves Outcomes for Hispanic Patients With Advanced Solid Tumors 2024 ·JCO Global Oncology ·(unknown), (unknown), Alejandro Ruíz-Patiño, (unknown), July Rodríguez, Darwin A. Moreno‐Pérez, (unknown), Jorge Otero, Carlos A. Vargas, Pilar Archila, Leonardo Rojas, (unknown), (unknown), Camila Ordóñez‐Reyes, Juan Esteban García-Robledo, (unknown), (unknown), Óscar Arrieta, Andrés F. Cardona	2
2	P59.14 Concordance and Performance of ddPCR Compared to NGS for The Detection of KRAS G12C Mutation 2021 ·Journal of Thoracic Oncology ·Alejandro Ruíz-Patiño, July Rodríguez, (unknown), Pilar Archila, Andrés F. Cardona, Cármen G. Sotelo, Hernán Carranza, (unknown), Jorge Otero, María A. Bermúdez, (unknown), Óscar Arrieta, (unknown), Luis Corrales, (unknown), Juan Esteban García-Robledo, (unknown), Christian Rolfo, Rafael Rosell	0
3	Highly proficient, balanced bilingualism is related to thinner cortex in two cognitive control regions 2020 ·Annals of the New York Academy of Sciences ·(unknown), Kelly A. Vaughn, Pilar Archila, Arturo E. Hernández	7
4	Human papillomavirus infection in metastatic lung adenocarcinoma is associated with better outcomes with immune checkpoint inhibitor treatment. 2020 ·Journal of Clinical Oncology ·(unknown), Alejandro Ruíz-Patiño, (unknown), July Rodríguez, (unknown), (unknown), Zyanya Lucía Zatarain-Barrón, Óscar Arrieta, Feliciano Barrón, Hernán Carranza, Jorge Otero, Carlos Vargas, Pilar Archila, (unknown), Claudio Martín, Luís Pino, Christian Rolfo, Rafael Rosell, Andrés F. Cardona, Gonzalo Recondo	1
5	Age of acquisition impacts the brain differently depending on neuroanatomical metric 2019 ·Human Brain Mapping ·(unknown), Kelly A. Vaughn, Pilar Archila, Arturo E. Hernández	17
6	PD1.05 Relevance of Antibiotic Use on Clinical Activity of Immune Checkpoint Inhibitors in Hispanic Patients with Advanced Non-small-cell Lung Cancer (CLICAP-ABs) 2019 ·Journal of Thoracic Oncology ·Feliciano Barrón, Andrés F. Cardona, Alejandro Ruíz-Patiño, (unknown), Luis Corrales, (unknown), (unknown), (unknown), (unknown), (unknown), Pilar Archila, Luís Más, H. Freitas, Vladmir Cláudio Cordeiro de Lima, José Javier Otero, Hernán Carranza, (unknown), Rafael Rosell	2
7	EP1.04-45 Relevance of Antibiotic Use on Clinical Activity of Immune Checkpoint Inhibitors in Hispanic Patients with Advanced NSCLC (CLICAP-ABs) 2019 ·Journal of Thoracic Oncology ·Feliciano Barrón, Óscar Arrieta, Andrés F. Cardona, Alejandro Ruíz-Patiño, (unknown), (unknown), Luis Corrales, Claudio Martín, (unknown), Juan M. Corchado, (unknown), (unknown), (unknown), Pilar Archila, Luís Más, H. Freitas, Vladmir Cláudio Cordeiro de Lima, (unknown), Hernán Carranza, (unknown), Rafael Rosell	2
8	Multigene Mutation Profiling and Clinical Characteristics of Small-Cell Lung Cancer in Never-Smokers vs. Heavy Smokers (Geno1.3-CLICaP) 2019 ·Frontiers in Oncology ·Andrés F. Cardona, Leonardo Rojas, Zyanya Lucía Zatarain-Barrón, Alejandro Ruíz-Patiño, Luisa Ricaurte, Luis Corrales, Claudio Martín, H. Freitas, Vladmir Cláudio Cordeiro de Lima, July Rodríguez, (unknown), (unknown), Pilar Archila, Hernán Carranza, Carlos Vargas, Jorge Otero, Feliciano Barrón, Niki Karachaliou, Rafael Rosell, Óscar Arrieta	22
9	EGFR Amplification and Sensitizing Mutations Correlate with Survival in Lung Adenocarcinoma Patients Treated with Erlotinib (MutP-CLICaP) 2018 ·Targeted Oncology ·Alejandro Ruíz-Patiño, (unknown), Luisa Ricaurte, Andrés F. Cardona, Leonardo Rojas, Zyanya Lucía Zatarain-Barrón, Beatriz Wills, Noemı́ Reguart, Hernán Carranza, Carlos Vargas, Jorge Otero, Luis Corrales, Claudio Martín, Pilar Archila, July Rodríguez, (unknown), (unknown), Luís Pino, Rafael Rosell, Óscar Arrieta	26
10	P1.02-050 Acquired Resistance to EGFR Tyrosine Kinase Inhibitors (TKIs) in EGFR-Mutant Lung Adenocarcinoma among Hispanics (Rbiop-CLICaP) 2017 ·Journal of Thoracic Oncology ·Andrés F. Cardona, Óscar Arrieta, Leonardo Rojas, Beatriz Wills, Noemı́ Reguart, Hernán Carranza, Carlos Vargas, Jorge Otero, Pilar Archila, Claudio Martín, Luis Corrales, Mauricio Cuello, (unknown), Sandra Franco, Rafael Rosell	2
11	Acquired Resistance to Erlotinib in EGFR Mutation-Positive Lung Adenocarcinoma among Hispanics (CLICaP) 2017 ·Targeted Oncology ·(unknown), Andrés F. Cardona, Óscar Arrieta, (unknown), Leonardo Rojas, Beatriz Wills, Noemı́ Reguart, Niki Karachaliou, Hernán Carranza, Carlos Vargas, Jorge Otero, Pilar Archila, Claudio Martín, Luis Corrales, Mauricio Cuello, (unknown), Luís Pino, Rafael Rosell, Zyanya Lucía Zatarain-Barrón	24
12	P1.02-055 Genotyping Squamous Cell Lung Carcinoma Among Hispanics (Geno1.1-CLICaP) 2017 ·Journal of Thoracic Oncology ·Andrés F. Cardona, Óscar Arrieta, Leonardo Rojas, Zyanya Lucía Zatarain-Barrón, Luis Corrales, Claudio Martín, July Rodríguez, J. Rodríguez, Pilar Archila, (unknown), Rafael Rosell	0
13	O.01: Acquired Resistance to EGFR-TKIs in EGFR-Mutant Lung Adenocarcinoma Among Hispanics (RBIOP-CLICaP) 2016 ·Journal of Thoracic Oncology ·Andrés F. Cardona, Óscar Arrieta, (unknown), Leonardo Rojas, Beatriz Wills, Hernán Carranza, Noemı́ Reguart, Carlos Vargas, Jorge Otero, Luis Corrales, Claudio Martín, Pilar Archila, Mauricio Cuello, (unknown), Rafael Rosell	1
14	BIM deletion polymorphisms in Hispanic patients with non-small cell lung cancer carriers of EGFR mutations 2016 ·Oncotarget ·Andrés F. Cardona, (unknown), Leonardo Rojas, Beatriz Wills, Óscar Arrieta, Hernán Carranza, Carlos Vargas, Jorge Otero, Luis Corrales, Claudio Martín, Noemı́ Reguart, Pilar Archila, July Rodríguez, Mauricio Cuello, (unknown), Sandra Franco, Christian Rolfo, Rafael Rosell	22
15	Neurothekeoma of the tongue in a 9-year-old child: Case report and literature review 2015 ·International Journal of Pediatric Otorhinolaryngology Extra ·(unknown), (unknown), (unknown), Pilar Archila, Rafael Parra‐Medina	0
16	Genotyping melanoma in Colombia. 2014 ·Journal of Clinical Oncology ·Hernán Carranza, Andrés F. Cardona, Carlos Vargas, Pilar Archila, Jorge Otero, (unknown), July Rodríguez, (unknown), (unknown), (unknown), (unknown), (unknown), Mauricio Lema, (unknown), (unknown), A.F. Yepes, Leonardo Rojas, Ricardo Jordão Duarte, (unknown), Óscar Arrieta	1
17	Características histológicas de la gastritis crónica reportadas en las biopsias gástricas de niños de 1 a 16 años de edad en el Hospital Infantil de San José, durante el período comprendido entre septiembre de 2008 a septiembre de 2010 2012 ·LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) ·Pilar Archila, (unknown), Mónica Ruiz	2
18	Outcomes in Latin American NSCLC patients harboring wild-type or activating mutations of EGFR (CLICaP Registry). 2012 ·Journal of Clinical Oncology ·Andrés F. Cardona, Óscar Arrieta, Guillermo F. Bramuglia, Alma D. Campos-Parra, (unknown), (unknown), Eduardo Richardet, (unknown), Pilar Archila, Rafael Rosell	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact